They found that the frequency of the variant was greater among breast cancer patients with a positive family history of breast cancer who do not carry germline mutations in the BRCA1 or BRCA2 genes, and in families with male breast cancer, as compared with healthy control individuals from the UK, The Netherlands, and North America [5]. The gene discussed is BRCA2; the disease is breast cancer.